Opinion

» policy, science policy and careers

Most Recent

image: Opinion: After We March

Opinion: After We March

By | March 16, 2017

How to become—and stay—involved in science policy 

4 Comments

image: Opinion: Sometimes, Scientists Must March

Opinion: Sometimes, Scientists Must March

By , , and | February 13, 2017

Lessons learned from the “Death of Evidence” demonstration in Canada

9 Comments

image: Opinion: The Scientist’s Scarlet Letter

Opinion: The Scientist’s Scarlet Letter

By | December 16, 2016

Managing privacy protections and expectations in a misconduct proceeding

0 Comments

Mentoring is critical for students just beginning to learn the ropes of biomedical research.

5 Comments

image: Opinion: Toot Your Horn

Opinion: Toot Your Horn

By | October 6, 2016

Why (and how) scientists should advocate for their research with journalists and policymakers

3 Comments

image: Opinion: Making Progress by Slowing Down

Opinion: Making Progress by Slowing Down

By | August 24, 2015

Academic research could be strengthened by thinking more and doing less.

5 Comments

Scientists at or near retirement can be ideal advisers for their junior colleagues. 

1 Comment

image: Opinion: Experiences of an Itinerant Scientist

Opinion: Experiences of an Itinerant Scientist

By | July 14, 2015

What I’ve learned doing science in three different countries 

1 Comment

image: Opinion: Abandoned by the System

Opinion: Abandoned by the System

By , , and | May 18, 2015

Lab techs and other highly qualified employees are too often given short shrift by the biomedical research enterprise.

0 Comments

image: Opinion: Separate Training from Research Budgets

Opinion: Separate Training from Research Budgets

By | October 7, 2014

In order to make the most of biomedical research funding and to better support trainees, institutions should recognize postdocs as employees.

2 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham